Skip to main content
. 2020 Nov 10;12(11):3316. doi: 10.3390/cancers12113316

Figure 4.

Figure 4

Pathophysiological mechanisms related to the coagulation dysfunctions in patients with COVID-19 and established risk factors in cancer patients that could increase coagulation and reduce the fibrinolysis.